NYSE:SYK - Stryker Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $268.18
  • Forecasted Upside: 2.11 %
  • Number of Analysts: 20
  • Breakdown:
  • 1 Sell Ratings
  • 6 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$262.64
▼ -0.1 (-0.04%)

This chart shows the closing price for SYK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Stryker Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SYK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SYK

Analyst Price Target is $268.18
▲ +2.11% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $268.18, with a high forecast of $303.00 and a low forecast of $215.00. The average price target represents a 2.11% upside from the last price of $262.64.

This chart shows the closing price for SYK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 20 polled investment analysts is to buy stock in Stryker. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 6 hold ratings
  • 2 sell ratings
3/30/2020
  • 1 strong buy ratings
  • 17 buy ratings
  • 7 hold ratings
  • 2 sell ratings
6/28/2020
  • 1 strong buy ratings
  • 16 buy ratings
  • 8 hold ratings
  • 2 sell ratings
9/26/2020
  • 1 strong buy ratings
  • 15 buy ratings
  • 9 hold ratings
  • 2 sell ratings
12/25/2020
  • 1 strong buy ratings
  • 14 buy ratings
  • 6 hold ratings
  • 2 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 1 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 1 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/1/2021Evercore ISIUpgradeIn-Line ➝ Outperform$260.00 ➝ $285.00High
5/24/2021BarclaysInitiated CoverageUnderweight$280.00Low
4/28/2021Truist SecuritiesBoost Price Target$245.00 ➝ $255.00Medium
4/28/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$264.00 ➝ $303.00Medium
4/28/2021OppenheimerBoost Price Target$240.00 ➝ $273.00High
4/28/2021TruistBoost Price Target$245.00 ➝ $255.00High
4/28/2021CitigroupBoost Price Target$264.00 ➝ $303.00High
4/28/2021Canaccord GenuityBoost Price TargetBuy$275.00 ➝ $285.00Medium
4/28/2021Morgan StanleyBoost Price TargetOverweight$265.00 ➝ $280.00Medium
4/28/2021Wells Fargo & CompanyBoost Price TargetOverweight$265.00 ➝ $300.00High
4/28/2021Raymond JamesBoost Price TargetOutperform$255.00 ➝ $290.00Medium
4/28/2021CowenBoost Price TargetOutperform$255.00 ➝ $279.00High
4/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$251.00 ➝ $285.00High
4/28/2021Robert W. BairdBoost Price TargetOutperform$265.00 ➝ $292.00High
2/24/2021JPMorgan Chase & Co.Boost Price TargetOverweight$245.00 ➝ $265.00Low
1/28/2021Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$278.00 ➝ $273.00Low
1/28/2021Morgan StanleyLower Price TargetOverweight$272.00 ➝ $265.00High
1/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$228.00 ➝ $251.00Low
1/28/2021Raymond JamesBoost Price TargetOutperform$240.00 ➝ $255.00Low
1/28/2021Needham & Company LLCReiterated RatingHoldLow
1/6/2021TruistBoost Price Target$210.00 ➝ $245.00N/A
1/6/2021Credit Suisse GroupBoost Price TargetOutperform$253.00 ➝ $278.00N/A
1/4/2021GuggenheimInitiated CoverageNeutralN/A
12/31/2020BTIG ResearchBoost Price TargetBuy$234.00 ➝ $252.00N/A
12/15/2020Morgan StanleyBoost Price TargetOverweight$225.00 ➝ $272.00Low
11/12/2020Robert W. BairdBoost Price TargetOutperform$243.00 ➝ $258.00Low
10/30/2020Smith Barney CitigroupBoost Price Target$232.00 ➝ $240.00High
10/30/2020SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $235.00High
10/30/2020Canaccord GenuityLower Price TargetBuy$240.00 ➝ $234.00High
10/30/2020Credit Suisse GroupBoost Price TargetOutperform$243.00 ➝ $253.00High
10/12/2020Raymond JamesBoost Price TargetOutperform$220.00 ➝ $240.00Medium
10/6/2020Northland SecuritiesInitiated CoverageMarket Perform$225.00Medium
9/28/2020Wells Fargo & CompanyBoost Price TargetOverweight$222.00 ➝ $232.00Medium
9/11/2020Wolfe ResearchInitiated CoverageMarket Perform$230.00Low
7/31/2020UBS GroupBoost Price TargetNeutral$202.00 ➝ $215.00High
7/31/2020Morgan StanleyBoost Price TargetOverweight$215.00 ➝ $225.00Low
7/31/2020SVB LeerinkBoost Price TargetOutperform$215.00 ➝ $225.00Medium
7/31/2020Credit Suisse GroupBoost Price TargetOutperform$237.00 ➝ $243.00High
7/31/2020Needham & Company LLCReiterated RatingHoldMedium
7/31/2020OppenheimerReiterated RatingHold$215.00Medium
7/31/2020CitigroupBoost Price TargetBuy$227.00 ➝ $232.00Medium
7/15/2020SVB LeerinkReiterated RatingOutperformLow
5/11/2020ArgusLower Price TargetBuy$240.00 ➝ $230.00Low
5/1/2020CitigroupBoost Price TargetBuy$200.00 ➝ $215.00Medium
5/1/2020CfraLower Price TargetStrong-Buy$234.00 ➝ $231.00Low
5/1/2020Wells Fargo & CompanyBoost Price TargetOverweight$201.00 ➝ $205.00Medium
5/1/2020Morgan StanleyBoost Price TargetOverweight$210.00 ➝ $215.00High
5/1/2020Stifel NicolausBoost Price TargetBuy$145.00 ➝ $205.00High
5/1/2020UBS GroupLower Price TargetNeutral$230.00 ➝ $202.00High
5/1/2020OppenheimerReiterated RatingHold$200.00Medium
5/1/2020Credit Suisse GroupBoost Price TargetOutperform$229.00 ➝ $237.00Medium
5/1/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$243.00 ➝ $228.00High
4/22/2020CowenLower Price TargetOutperform$240.00 ➝ $220.00Low
4/15/2020JPMorgan Chase & Co.Lower Price TargetOverweight$240.00 ➝ $210.00Medium
4/13/2020Raymond JamesLower Price TargetOutperform$240.00 ➝ $205.00High
4/13/2020BarclaysDowngradeEqual Weight ➝ Underweight$155.00High
4/1/2020Wells Fargo & CompanyLower Price TargetOverweight$243.00 ➝ $201.00Medium
4/1/2020The Goldman Sachs GroupDowngradeBuy ➝ Sell$248.00 ➝ $150.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$250.00 ➝ $210.00Low
3/27/2020CitigroupLower Price TargetBuy$235.00 ➝ $200.00Medium
3/25/2020Credit Suisse GroupLower Price TargetOutperform$247.00 ➝ $162.00Low
3/24/2020Stifel NicolausLower Price TargetBuy$250.00 ➝ $145.00High
3/6/2020Credit Suisse GroupLower Price TargetOutperform$255.00 ➝ $247.00Low
3/4/2020CitigroupInitiated CoverageBuy$235.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$248.00Low
1/30/2020BTIG ResearchReiterated RatingBuyMedium
1/29/2020Cantor FitzgeraldReiterated RatingNeutralMedium
1/29/2020Stifel NicolausBoost Price TargetBuy$245.00 ➝ $250.00Low
1/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$239.00 ➝ $243.00Low
1/29/2020Robert W. BairdBoost Price TargetOutperform$242.00 ➝ $248.00High
1/29/2020Morgan StanleyBoost Price TargetOverweight$242.00 ➝ $250.00High
1/7/2020SunTrust BanksInitiated CoverageHold$217.00Low
1/7/2020Piper SandlerDowngradeOverweight ➝ Neutral$210.00Low
1/7/2020Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$210.00Medium
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$179.00Low
1/2/2020Evercore ISIUpgradeIn-Line ➝ OutperformLow
12/30/2019BTIG ResearchBoost Price TargetBuy$228.00 ➝ $236.00Low
12/17/2019Morgan StanleyBoost Price TargetOverweight$230.00 ➝ $242.00High
11/5/2019BarclaysDowngradeOverweight ➝ Equal Weight$226.00 ➝ $207.00High
10/30/2019Robert W. BairdBoost Price TargetOutperform$239.00 ➝ $242.00Medium
10/30/2019Canaccord GenuityBoost Price TargetBuy$233.00 ➝ $240.00Medium
10/30/2019Bank of AmericaBoost Price TargetBuy$220.00 ➝ $245.00High
9/5/2019BTIG ResearchSet Price TargetBuy$228.00Medium
9/4/2019Piper Jaffray CompaniesReiterated RatingBuyLow
7/29/2019BTIG ResearchReiterated RatingBuy$228.00Low
7/26/2019Raymond JamesSet Price TargetBuy$240.00Low
7/26/2019Royal Bank of CanadaSet Price TargetBuy$220.00Low
7/26/2019BMO Capital MarketsSet Price TargetHold$216.00Low
7/26/2019BarclaysSet Price TargetBuy$226.00N/A
7/26/2019Robert W. BairdBoost Price TargetOutperform$206.00 ➝ $239.00Low
7/26/2019Credit Suisse GroupBoost Price TargetOutperform$232.00 ➝ $237.00Low
7/26/2019Cantor FitzgeraldBoost Price TargetNeutral$190.00 ➝ $230.00High
7/26/2019Canaccord GenuityBoost Price TargetBuy$195.00 ➝ $233.00High
7/26/2019Piper Jaffray CompaniesBoost Price TargetOverweight$205.00 ➝ $240.00High
7/16/2019Morgan StanleyBoost Price TargetOverweight$218.00 ➝ $230.00Low
7/15/2019BTIG ResearchBoost Price TargetBuy ➝ Positive$219.00Medium
7/11/2019Credit Suisse GroupBoost Price TargetOutperform$200.00 ➝ $232.00Low
7/10/2019SVB LeerinkReiterated RatingOutperformLow
7/2/2019Wells Fargo & CompanyBoost Price TargetOutperform$219.00 ➝ $228.00Low
4/24/2019OppenheimerBoost Price TargetOutperform$183.00 ➝ $192.00Low
4/24/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$201.00 ➝ $206.00Low
4/24/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$181.00 ➝ $208.00Low
4/24/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$190.00 ➝ $195.00Low
4/24/2019Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$175.00 ➝ $190.00Low
4/15/2019BarclaysBoost Price TargetOverweight ➝ Overweight$203.00 ➝ $211.00Low
4/1/2019Wells Fargo & CompanyBoost Price TargetOutperform$214.00 ➝ $219.00Low
3/19/2019JPMorgan Chase & Co.Boost Price TargetOverweight$200.00 ➝ $215.00Medium
3/18/2019BTIG ResearchBoost Price TargetBuy$211.00Low
3/11/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$184.00 ➝ $204.00Medium
3/8/2019BarclaysSet Price TargetBuy$203.00Low
3/4/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $218.00Low
3/1/2019Piper Jaffray CompaniesReiterated RatingOverweight$205.00Medium
2/4/2019SunTrust BanksBoost Price TargetBuy ➝ Positive$205.00Low
1/31/2019Credit Suisse GroupUpgradeOutperformMedium
1/30/2019Canaccord GenuityBoost Price TargetBuy$185.00 ➝ $190.00High
1/18/2019Cantor FitzgeraldReiterated RatingNeutralMedium
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$179.00Medium
1/2/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$212.00 ➝ $197.00Low
1/2/2019CitigroupLower Price TargetNeutral ➝ Neutral$174.00 ➝ $169.00Low
1/2/2019Evercore ISIUpgradeIn-Line ➝ Outperform$156.75Medium
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$195.00Low
11/27/2018UBS GroupInitiated CoverageNeutral$180.00 ➝ $180.00High
11/15/2018CitigroupBoost Price TargetNeutral ➝ Neutral$173.00 ➝ $174.00Medium
11/9/2018OppenheimerSet Price TargetHold$170.00N/A
11/9/2018CowenSet Price TargetBuy$195.00Low
11/9/2018Needham & Company LLCReiterated RatingHoldLow
10/26/2018OppenheimerSet Price TargetHold$170.00Medium
10/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$198.00High
9/13/2018JPMorgan Chase & Co.Boost Price TargetOverweight$200.00Medium
9/12/2018BTIG ResearchReiterated RatingBuy$187.00Low
9/11/2018Needham & Company LLCReiterated RatingHoldLow
8/16/2018BTIG ResearchInitiated CoverageBuy$187.00Medium
7/25/2018OppenheimerSet Price TargetHold$170.00Medium
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$187.00 ➝ $192.00Medium
7/25/2018Canaccord GenuityReiterated RatingBuy$185.00Medium
7/25/2018CitigroupBoost Price TargetNeutral ➝ Neutral$171.00 ➝ $173.00High
7/25/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$170.00 ➝ $175.00High
7/25/2018Royal Bank of CanadaReiterated RatingBuy$184.00High
7/25/2018Needham & Company LLCReiterated RatingHoldHigh
7/12/2018BMO Capital MarketsReiterated RatingHold$174.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$177.00Medium
6/13/2018Cantor FitzgeraldReiterated RatingHold$170.00Low
5/1/2018CitigroupBoost Price TargetNeutral ➝ Neutral$166.00 ➝ $171.00Low
4/27/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$176.00 ➝ $185.00Medium
4/27/2018BMO Capital MarketsBoost Price TargetMarket Perform$170.00Medium
4/27/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$183.00 ➝ $187.00Low
4/27/2018Cantor FitzgeraldReiterated RatingHold ➝ NeutralHigh
4/2/2018Evercore ISIInitiated CoverageIn-Line$165.00Medium
3/15/2018Raymond JamesInitiated CoverageOutperform$183.00Low
2/27/2018CitigroupUpgradeSell ➝ Neutral$165.77 ➝ $166.00Medium
2/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$179.00 ➝ $186.00High
2/1/2018OppenheimerReiterated RatingHold$165.00Low
2/1/2018CitigroupReiterated RatingMarket Perform$156.00 ➝ $165.00Low
1/31/2018GuggenheimReiterated RatingBuyLow
1/31/2018Piper Jaffray CompaniesReiterated RatingBuy$170.00Low
1/31/2018Needham & Company LLCReiterated RatingHoldMedium
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$177.00 ➝ $184.00Low
1/30/2018Cantor FitzgeraldReiterated RatingHold$163.00Medium
1/26/2018SunTrust BanksReiterated RatingBuy ➝ Buy$161.00 ➝ $179.00Low
1/17/2018Needham & Company LLCReiterated RatingHoldLow
1/9/2018Royal Bank of CanadaReiterated RatingBuy$175.00Low
1/9/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$156.00 ➝ $166.00Low
1/5/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$163.00Medium
1/2/2018Wells Fargo & CompanyReiterated RatingOutperform$166.00 ➝ $174.00Medium
1/2/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightMedium
12/12/2017BMO Capital MarketsUpgradeMarket Perform$163.00Low
12/7/2017Needham & Company LLCReiterated RatingHoldLow
11/24/2017Robert W. BairdUpgradeNeutral ➝ OutperformN/A
11/17/2017SunTrust BanksReiterated RatingBuy$161.00N/A
11/16/2017Robert W. BairdUpgradeNeutral ➝ Outperform$161.00 ➝ $173.00N/A
11/3/2017Needham & Company LLCReiterated RatingHoldN/A
10/30/2017OppenheimerSet Price TargetHold$148.00 ➝ $156.00N/A
10/29/2017CowenSet Price TargetBuy$166.00N/A
10/27/2017BarclaysBoost Price TargetUnderweight$137.00 ➝ $148.00N/A
10/27/2017Canaccord GenuityBoost Price TargetBuy ➝ Buy$155.00 ➝ $162.00N/A
10/27/2017Stifel NicolausBoost Price TargetBuy$158.00 ➝ $168.00N/A
10/27/2017Wells Fargo & CompanyBoost Price Target$160.00 ➝ $166.00N/A
10/27/2017Piper Jaffray CompaniesReiterated RatingBuy$156.00N/A
10/27/2017Robert W. BairdReiterated RatingHold$161.00N/A
10/6/2017CowenSet Price TargetBuy$160.00N/A
10/2/2017Royal Bank of CanadaReiterated RatingBuy$155.00Low
10/2/2017SunTrust BanksReiterated RatingBuy$161.00Medium
9/1/2017Royal Bank of CanadaReiterated RatingBuy$155.00N/A
8/29/2017ArgusReiterated RatingBuy$160.00Low
8/25/2017Needham & Company LLCUpgradeUnderperform ➝ HoldLow
8/24/2017Piper Jaffray CompaniesReiterated RatingOverweight$148.00Low
8/24/2017Canaccord GenuityReiterated RatingBuy$158.00 ➝ $155.00Low
8/23/2017OppenheimerReiterated RatingHoldLow
7/30/2017CowenReiterated RatingBuy$150.00 ➝ $160.00Low
7/28/2017Stifel NicolausBoost Price TargetBuy$151.00 ➝ $158.00High
7/28/2017OppenheimerSet Price TargetHold$148.00High
7/28/2017Royal Bank of CanadaBoost Price TargetOutperform$140.00 ➝ $155.00High
7/11/2017BMO Capital MarketsReiterated RatingHold$140.00Low
7/10/2017Morgan StanleyReiterated RatingOverweight$155.00 ➝ $160.00Low
6/30/2017Jefferies Financial GroupReiterated RatingHold$132.00Low
6/29/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$153.00Low
6/21/2017Morgan StanleyBoost Price TargetOverweight$145.00 ➝ $155.00Low
6/19/2017OppenheimerReiterated RatingHoldLow
6/9/2017CitigroupBoost Price TargetSell$114.00 ➝ $125.00Low
5/16/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$129.00Medium
4/29/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$135.00 ➝ $148.00Low
4/27/2017BarclaysReiterated RatingSell$133.00Low
4/26/2017CowenSet Price TargetOutperform$135.00 ➝ $150.00Low
4/26/2017Royal Bank of CanadaReiterated RatingOutperform$135.00 ➝ $140.00Medium
4/26/2017Needham & Company LLCReiterated RatingSellMedium
4/17/2017Piper Jaffray CompaniesReiterated RatingOverweight$148.00Low
4/13/2017Jefferies Financial GroupReiterated RatingHold$132.00Low
4/11/2017BMO Capital MarketsReiterated RatingHold$125.00Low
4/8/2017OppenheimerSet Price TargetHold$135.00Low
3/13/2017Morgan StanleyBoost Price TargetOverweight$135.00 ➝ $145.00Low
3/3/2017Royal Bank of CanadaBoost Price TargetOutperform$129.00 ➝ $135.00N/A
2/27/2017Canaccord GenuityReiterated RatingBuy$137.00N/A
1/28/2017Wells Fargo & CompanyReiterated RatingOutperform$134.50N/A
1/25/2017OppenheimerSet Price TargetHold$122.00N/A
1/25/2017GuggenheimSet Price TargetBuy$137.00N/A
1/25/2017Jefferies Financial GroupBoost Price TargetHold$120.00 ➝ $132.00N/A
1/25/2017BarclaysBoost Price TargetUnderweight$120.00 ➝ $122.00N/A
1/25/2017Needham & Company LLCReiterated RatingSellN/A
1/25/2017Canaccord GenuityBoost Price TargetBuy$127.00 ➝ $137.00N/A
1/23/2017Canaccord GenuityBoost Price TargetBuy$127.00 ➝ $137.00N/A
1/6/2017Needham & Company LLCDowngradeHold ➝ UnderperformN/A
1/6/2017Royal Bank of CanadaReiterated RatingBuy$129.00N/A
1/5/2017Edward JonesDowngradeBuy ➝ HoldN/A
12/21/2016UBS GroupUpgradeNeutral ➝ Buy$121.00 ➝ $133.00N/A
12/15/2016UBS GroupUpgradeNeutral ➝ BuyN/A
11/13/2016Needham & Company LLCReiterated RatingHoldN/A
11/1/2016BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$125.00N/A
10/30/2016Canaccord GenuitySet Price TargetBuy$127.00N/A
10/30/2016OppenheimerSet Price TargetHold$122.00N/A
10/13/2016SunTrust BanksInitiated CoverageBuy$140.00N/A
7/25/2016Brean CapitalReiterated RatingBuy$121.00 ➝ $125.00N/A
7/25/2016Jefferies Financial GroupReiterated RatingHold$113.00 ➝ $120.00N/A
7/24/2016Canaccord GenuityReiterated RatingBuy$130.00N/A
7/24/2016Needham & Company LLCReiterated RatingHoldN/A
7/22/2016JPMorgan Chase & Co.Reiterated RatingHold$119.00N/A
7/22/2016UBS GroupReiterated RatingBuy$112.00 ➝ $121.00N/A
7/22/2016Piper Jaffray CompaniesBoost Price TargetOverweight$120.00 ➝ $135.00N/A
7/19/2016Credit Suisse GroupReiterated RatingOutperform$110.00 ➝ $124.00N/A
(Data available from 6/23/2016 forward)
Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More

Today's Range

Now: $262.64
Low: $261.50
High: $264.37

50 Day Range

MA: $256.26
Low: $244.76
High: $267.00

52 Week Range

Now: $262.64
Low: $171.75
High: $268.04

Volume

1,115,928 shs

Average Volume

1,167,297 shs

Market Capitalization

$98.95 billion

P/E Ratio

71.18

Dividend Yield

0.96%

Beta

0.96

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?

The following sell-side analysts have issued reports on Stryker in the last year: Barclays PLC, BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer Holdings Inc., Raymond James, Robert W. Baird, Smith Barney Citigroup, SVB Leerink LLC, TheStreet, Truist, Truist Securities, UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for SYK.

What is the current price target for Stryker?

22 Wall Street analysts have set twelve-month price targets for Stryker in the last year. Their average twelve-month price target is $268.18, suggesting a possible upside of 2.1%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting SYK will reach $303.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $215.00 for Stryker in the next year.
View the latest price targets for SYK.

What is the current consensus analyst rating for Stryker?

Stryker currently has 1 sell rating, 6 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SYK will outperform the market and that investors should add to their positions of Stryker.
View the latest ratings for SYK.

What other companies compete with Stryker?

How do I contact Stryker's investor relations team?

Stryker's physical mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company's listed phone number is (269) 385-2600 and its investor relations email address is [email protected] The official website for Stryker is www.strykercorp.com.